Neuroscience

Fibril Structure and Alzheimer Disease

From a Salk Institute for Biological Studies press release:

Released: Fri 11-Nov-2005, 08:55 ET
Embargo expired: Mon 14-Nov-2005, 17:00 ET

3-D Structure of Alzheimer's Disease Filament Shows How It Zips Up Peptides

Newswise — Researchers have solved the three dimensional structure of the long thread-like fibers that fill the brains of Alzheimer's disease patients. The structure reveals the proteins that make up the fibrils lock onto each other much like a zipper on a jacket. This advance, reported in the Nov. 14th early online edition of Proceedings of the National Academy of Sciences (PNAS), helps illuminate the molecular roots of Alzheimer's and possibly other degenerative diseases of the brain.

“Now that we understand at an atomic level how these fibrils form, it might help researchers develop a biomarker test to diagnose Alzheimer's disease at an early stage, as well as drugs to treat it,” says the study's lead investigator, Salk Institute for Biological Studies scientist Roland Riek, Ph.D., who collaborated with researchers at the University of Lausanne and Roche pharmaceuticals, both in Switzerland

As a result of the study, Riek and his colleagues may now understand how a potential Alzheimer's disease medication now in clinical trials in Europe reacts to the fibril. The drug binds to the end of the fibril chain of beta amyloid proteins, halting their lethal accumulation, an early step in the formation of the amyloid plaque deposits that are a hallmark of Alzheimer's.

[snip]

The research team of the Salk Institute in collaboration with the University of Lausanne and Roche, developed new research techniques to determine the 3D structure that mimics the most common type of fibrils found in patients with the disease.

They discovered that beta amyloid proteins (peptides) that make up these fibrils attach to each other on one end with an ever-growing property.

“From this structure we can nicely see what happens physically, where the fibril forms a template on which to bind other amyloid peptides in an inter-collated way,” Riek says. “The way these peptides lock on to each other is like a zipper on a jacket.” Due to the ever-growing property the zipper binds more and more loose peptides together to produce dense “plaque” filaments that may be toxic to the functioning of brain nerve cells.

-
Anthony H. Risser | neuroscience | neuropsychology | brain

- Alzheimer's Disease
In Preventing Alzheimer’s, Mutation May Aid Drug Quest The New York Times By GINA KOLATA 11 July 2012 [snip] Two decades ago, researchers began discovering rare gene mutations that cause Alzheimer’s disease in all who inherit them. Now, they have...

- Neuropsychology Abstract Of The Day: Alzheimer's Disease
Amyloid-beta levels are significantly reduced and spatial memory defects are rescued in a novel neuroserpin-deficient Alzheimer's disease transgenic mouse model J Neurochem. 2011 Sep; 118(5): 928-38 Authors: Fabbro S, Schaller K, Seeds NW Abstract...

- Alzheimer's Disease: Targeting The Blood-brain Barrier
A news release from the NIH: Targeting the Blood-Brain Barrier May Delay Progression of Alzheimer's Disease 12 April 2010Researchers may be one step closer to slowing the onset and progression of Alzheimer's disease. An animal study supported...

- Business World: Neurochem's Alzhemed And Alzheimer Disease
Neurochem completes patient recruitment for North American Phase III clinical trial for Alzhemed(TM) Milestone on Schedule Tuesday July 5, 8:31 am ET LAVAL, QC, July 5 /PRNewswire-FirstCall/ - Neurochem Inc. ... announced today the completion of recruitment...

- Alzheimer Disease
From The Boston Globe: Mind mystery Alzheimer's disease appears to have multiple causes, and scientists are slowly unraveling them By Alice Dembner, Globe Staff March 29, 2005 A century after Alois Alzheimer identified the debilitating dementia that...

Neuroscience